Zirus has many novel targets for the development of drugs that could potentially anticipate and treat whatever form of pandemic flu emerges.

Our process allows us to find common human host genes that potentially all influenza strains use to replicate. Shutting the product of those genes down stops the ability of the virus to replicate. These principles also apply to SARS and other potential pandemic viruses.

Broad spectrum antiviral drugs - Zirus Antivirotics^(TM) - can be used to design and develop drugs to anticipate pandemic flu and other global threats.